Chemed director receives 386-share stock award
WALSH GEORGE J III reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
WALSH GEORGE J III reported acquisition or exercise transactions in this Form 4 filing.
CHEMED CORP director WALSH GEORGE J III reported a stock award of 386 shares of Capital Stock. The shares were granted at a reported price of $440.77 per share as a compensation-related award. Following this grant, he directly holds 3,709 shares. A separate entry shows indirect ownership of 434 shares held by his spouse, reflecting family holdings rather than a new market trade.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Capital Stock | 386 | $440.77 | $170K |
| Holding | Capital Stock | -- | -- | -- |
Footnotes (1)
- F1. Award of stock
Key Figures
Key Terms
Grant, award, or other acquisition financial
Capital Stock financial
indirect financial
spouse financial
Award of stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CHEMED CORP (CHE) director George J. Walsh III report in this Form 4?
Was the CHEMED CORP Form 4 transaction a stock purchase or a grant?
Does the CHEMED CORP Form 4 show any stock sales by George J. Walsh III?
AI-generated analysis. How Rhea-AI works. Not financial advice.